Five Fraction SBRT Noninferior to Moderately Fractionated Image-Guided Radiotherapy for Patients with Low to Intermediate Risk Localised Prostate Cancer By Ogkologos - November 7, 2024 719 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PACE-B study Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR EMA Recommends Granting a Conditional Marketing Authorisation for Adagrasib Following a Re-Examination... November 17, 2023 Patients Diagnosed with Cancer During Pregnancy May Have Increased Risk of... April 27, 2023 Longer Duration of Treatment with ICIs Associated with a Higher Rate... March 5, 2025 Young Breast Cancer Survivor Killed in Hit and Run Crash Weeks... August 25, 2021 Load more HOT NEWS Neoadjuvant Dabrafenib Plus Trametinib Has High Pathological Response Rates in Clinical... New on NCI’s Websites for December 2022 EMA Recommends Granting a Marketing Authorisation for Akeega, Fixed-Dose Combinations of... Adding Tafasitamab to Lenalidomide and Rituximab Prolongs PFS in Patients with...
